Pharmaceutical Compliance Consulting in United Arab Emirates
PHARPRO delivers CSV validation, QA gap assessments, CQV, thermal mapping, and GMP training for pharmaceutical companies in United Arab Emirates - remotely and on-site. Aligned with UAE Ministry of Health & Prevention (MoHAP), Health Authority Abu Dhabi (HAAD), Dubai Health Authority (DHA).
Understanding the UAE Pharmaceutical Landscape
The UAE pharmaceutical sector is one of the fastest-growing in the MENA region, with over 30 licensed manufacturers and a rapidly expanding wholesale and distribution network. MoHAP aligns closely with ICH and PIC/S guidelines, meaning pharmaceutical companies in the UAE face the same regulatory rigour as European and US markets.
PHARPRO has worked with pharmaceutical clients across United Arab Emirates - both remotely and on-site - delivering CSV validation, QA support, and GMP training that meets the regulatory expectations your team faces.
Compliance Services for UAE Pharma
Remote and on-site support, delivered at the pace your programme requires.
CSV Validation
Full-lifecycle CSV for pharma software and laboratory systems. IQ/OQ/PQ, URS, risk classification, and audit trail review - aligned with EU GMP Annex 11 and FDA 21 CFR Part 11.
QA & Gap Assessment
Gap assessments against UAE Ministry of Health & Prevention (MoHAP), Health Authority Abu Dhabi (HAAD), Dubai Health Authority (DHA) and international GMP standards. SOP reviews, CAPA management, and data integrity programmes.
CQV & Thermal Mapping
Equipment and utility qualification (IQ/OQ/PQ) and temperature mapping studies for UAE pharmaceutical warehouses, cold chain facilities, and manufacturing areas.
GMP Training
Customised GMP training for UAE pharma teams - data integrity, CSV fundamentals, IQ/OQ/PQ methodology, and inspection readiness.
Inspection Readiness
Mock audits and gap assessments to prepare your UAE site for UAE Ministry of Health & Prevention (MoHAP), Health Authority Abu Dhabi (HAAD), Dubai Health Authority (DHA) inspections and international authority audits.
CAPA Management
Root cause analysis, corrective and preventive action planning, and CAPA effectiveness checks - aligned with ICH Q10 and GMP requirements.
Regulations We Work Within in UAE
All PHARPRO work in United Arab Emirates is aligned with applicable local and international regulatory standards.
Frequently Asked Questions - UAE
Yes. PHARPRO serves pharmaceutical manufacturers, distributors, and contract organisations across United Arab Emirates - both remotely and on-site. We have supported UAE clients with CSV validation, QA gap assessments, GMP training, and inspection readiness.
Pharmaceutical companies in United Arab Emirates must comply with UAE Ministry of Health & Prevention (MoHAP), Health Authority Abu Dhabi (HAAD), Dubai Health Authority (DHA) requirements, which are closely aligned with UAE Ministry of Health & Prevention (MoHAP) GMP Guidelines, Health Authority Abu Dhabi (HAAD) pharmaceutical licensing requirements, Dubai Health Authority (DHA) regulations. Export-focused manufacturers must additionally comply with the regulatory requirements of their target markets.
Yes. PHARPRO delivers CSV documentation, QA assessments, gap analyses, and training programmes remotely with no loss in quality. For on-site work such as thermal mapping, facility walkthroughs, or mock inspections, our consultants travel to United Arab Emirates.
For urgent situations - imminent inspection or regulatory finding - PHARPRO can begin remote work within 3–5 business days. For planned projects, the typical kickoff is 1–2 weeks after proposal agreement.
Ready to start your UAE compliance project?
Start with a free 30-minute compliance assessment. No commitment, no sales pitch.